Article | September 17, 2021

AI(d) To Increase Drug Discovery Productivity And Optimize SPR Data Interpretation

Source: Cytiva

By Paul Belcher, Product Strategy Manager, and Martin Teichert, Global Product Manager, Cytiva


Due to the high attrition rates in drug development, there is increasing pressure in the pharmaceutical industry, yet the efficiency of research and development has not increased. Developers have more samples to test and more information to collect, with less time to make decisions.

Therefore, there’s demand for information-rich technologies that can be applied earlier in the drug discovery process. While some of the current data analysis tools have improved, developers are still faced with time-consuming, manual approaches.

Explore a machine learning solution to optimize how developers analyze and characterize their early drug candidates.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online